UA97233C2 - Процес виробництва вакцин - Google Patents

Процес виробництва вакцин Download PDF

Info

Publication number
UA97233C2
UA97233C2 UAA200714085A UAA200714085A UA97233C2 UA 97233 C2 UA97233 C2 UA 97233C2 UA A200714085 A UAA200714085 A UA A200714085A UA A200714085 A UAA200714085 A UA A200714085A UA 97233 C2 UA97233 C2 UA 97233C2
Authority
UA
Ukraine
Prior art keywords
solution
saccharide
conjugate
minutes
added
Prior art date
Application number
UAA200714085A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Ральф Леон Биманс
Пьер Дювивье
Original Assignee
ГлаксоСмитКлайн Байолоджикалз с.а.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ГлаксоСмитКлайн Байолоджикалз с.а. filed Critical ГлаксоСмитКлайн Байолоджикалз с.а.
Priority claimed from PCT/EP2006/006270 external-priority patent/WO2007000343A2/en
Publication of UA97233C2 publication Critical patent/UA97233C2/uk

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
UAA200714085A 2005-06-27 2006-06-23 Процес виробництва вакцин UA97233C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0513069.5A GB0513069D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
PCT/EP2006/006270 WO2007000343A2 (en) 2005-06-27 2006-06-23 Process for manufacturing vaccines

Publications (1)

Publication Number Publication Date
UA97233C2 true UA97233C2 (uk) 2012-01-25

Family

ID=34856207

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200714085A UA97233C2 (uk) 2005-06-27 2006-06-23 Процес виробництва вакцин

Country Status (7)

Country Link
CN (4) CN101247827B (enrdf_load_stackoverflow)
ES (1) ES2367918T5 (enrdf_load_stackoverflow)
FR (1) FR12C0060I2 (enrdf_load_stackoverflow)
GB (1) GB0513069D0 (enrdf_load_stackoverflow)
NO (2) NO2021022I1 (enrdf_load_stackoverflow)
UA (1) UA97233C2 (enrdf_load_stackoverflow)
ZA (3) ZA200710853B (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104302315B (zh) * 2012-01-30 2018-02-06 印度血清研究所私人有限公司 免疫原性组合物及其制备方法
PL2885007T3 (pl) * 2012-08-16 2019-02-28 Pfizer Inc. Sposoby glikokoniugacji i kompozycje
CA3033364A1 (en) * 2016-09-02 2018-03-08 Sanofi Pasteur, Inc. Neisseria meningitidis vaccine
US20230137914A1 (en) * 2016-11-25 2023-05-04 Glaxosmithkline Biologicals, S.A. nOMV-ANTIGEN CONJUGATED COMPOUNDS AND USE THEREOF
CN109879967A (zh) * 2017-12-15 2019-06-14 苏州和锐生物科技有限公司 一种乙酰氨基葡萄糖偶联物的制备方法及应用
CN110251667A (zh) * 2018-05-11 2019-09-20 武汉博沃生物科技有限公司 一种免疫组合制剂及其制备方法和应用
WO2021099982A1 (en) * 2019-11-22 2021-05-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
CN115819616B (zh) * 2021-07-28 2025-04-11 江苏瑞科生物技术股份有限公司 一种基因重组vzv融合蛋白及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180815A (en) * 1988-04-13 1993-01-19 Fuji Photo Film Co., Ltd. Modified protein for carrying hapten
WO2002000249A2 (en) * 2000-06-29 2002-01-03 Glaxosmithkline Biologicals S.A. Multivalent vaccine composition
WO2002080964A1 (en) * 2001-04-06 2002-10-17 Institut Pasteur Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of vibrio cholerae 0139 bound to tetanus toxoid
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
CN1401328A (zh) * 2002-10-18 2003-03-12 北京绿竹生物技术有限责任公司 流行性脑脊髓膜炎多糖－蛋白结合疫苗
PT2172213E (pt) * 2003-01-30 2013-06-03 Novartis Ag Vacinas injetáveis contra múltiplos serogrupos meningocócicos

Also Published As

Publication number Publication date
CN101222935B (zh) 2015-07-29
CN101222935A (zh) 2008-07-16
CN101208103B (zh) 2013-04-24
ZA200710909B (en) 2009-04-29
CN101247827A (zh) 2008-08-20
ZA200711074B (en) 2009-07-29
FR12C0060I1 (enrdf_load_stackoverflow) 2012-12-14
CN101208103A (zh) 2008-06-25
CN101208101B (zh) 2013-01-02
CN101247827B (zh) 2013-07-17
NO2021022I1 (no) 2021-05-25
ZA200710853B (en) 2009-04-29
GB0513069D0 (en) 2005-08-03
CN101208101A (zh) 2008-06-25
NO2025018I1 (no) 2025-04-08
ES2367918T5 (es) 2014-11-21
ES2367918T3 (es) 2011-11-10
FR12C0060I2 (fr) 2017-01-06

Similar Documents

Publication Publication Date Title
JP7268125B2 (ja) コンジュゲート化莢膜糖類抗原を含む免疫原性組成物、それを含むキットおよびこれらの使用
RU2762723C2 (ru) Иммуногенные композиции для применения в пневмококковых вакцинах
KR101408113B1 (ko) 백신 제조 방법
US9168313B2 (en) Vaccine
UA97233C2 (uk) Процес виробництва вакцин
JP2022075575A (ja) 肺炎球菌ワクチンにおける使用のための免疫原性組成物
RU2827429C1 (ru) Иммуногенные композиции для применения в пневмококковых вакцинах
US20150079129A1 (en) Vaccine
MXPA01009455A (en) Vaccine
HK1229726A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
MXPA01009459A (es) Vacuna
HK1114012A (en) Vaccine